A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 10 May 2023) has been published and includes articles on:
Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment
Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions instead of saline solutions in arterial lines
Febuxostat: updated advice for the treatment of patients with a history of major cardiovascular disease
Letters and medicine recalls sent to healthcare professionals in April 2023.
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.